FDA Pediatric Advisory Committee

Adverse effects of montelukast examined by FDA's Pediatric Advisory CommitteeAt its late September meeting, the Pediatric Advisory Committee (PAC) to the US Food and Drug Administration (FDA) said it’s time to remind healthcare professionals that Singulair (montelukast) may have adverse effects on mental and behavioral functions.
Children's prosthetic thoracic device passes FDA postmarket reviewThe “titanium rib,” a surgically implanted device to treat thoracic insufficiency syndrome, passed through a postmarket review by the US Food and Drug Administration (FDA) Pediatric Advisory Committee in April with flying colors and plaudits from the committee members.